Mar 31 2023

george

March 2023 Quick Question: Apixaban Reversal

Our March 2023 Quick Question asked, “Which reversal agent is effective in managing apixaban overdose?” Our 45 respondents chose: rFVIIa [NovoSeven]: 4 [9%] Andexanet alfa: 28 [62%] Idarucizumab: 5 [11%] Vitamin K: 6 [13%] FFP: 2 [5%] Before direct reversal agents became available, DOAC overdose-related bleeding was treated by attempting to absorb undigested anticoagulant from […]

read more

Comments (0)

Anticoagulant Therapy

Mar 28 2023

george

Dabigatran Recall

Thanks to Dave McGlasson for forwarding this Medscape bulletin [click] announcing Ascend Laboratories’ recall of 10 dabigatran lots due to the detection of the nitrosamine impurity, N-nitroso-dabigatran, a potential carcinogen.

read more

Comments (0)

Anticoagulant Therapy

Mar 25 2023

george

Mixed DOACs and the DOAC Clotting Time Test

In a January 2023 letter to the editor, available from the publisher or your library as Exner T, Ellwood L, Dangol M, Favaloro EJ. Mixing factor Xa and thrombin inhibiting direct oral anticoagulants produces a synergistic prolonging effect on most clotting tests. Int J Lab Hematol. 2023 Feb 21. doi: 10.1111/ijlh.14043, investigators examined a DRVVT-based […]

read more

Comments (1)

Anticoagulant Therapy

Mar 1 2023

george

March 2023 Quick Question: Apixaban Reversal

Our March 2023 Quick Question addresses DOAC reversal and asks, “Which reversal agent is effective in managing apixaban overdose?” Please give us your best selection and add your comments in our Comments section below this post. The question will be available through March 31.

read more

Comments (0)

Anticoagulant Therapy

Jan 31 2023

george

January, 2023 Quick Question: Tranexamic Acid

Our January 2023 Quick Question asks, What is the target of the anti-hemorrhagic agent tranexamic acid? For this question, the only correct answer is fibrinolysis. Here are the responses from our 57 participants… Factor V: 5 [9%] Factor XIII: 5 [9%] Fibrinolysis: 40 [70%] Prothrombin  4 [7%] Activated protein C 3 [5%] This QQ is […]

read more

Comments (0)

Quick Question Archive

Dec 30 2022

george

Apixaban and Alzheimer Disease

Michele M. Reed participated in my [Geo] Michigan State University’s Biomedical Laboratory Diagnostics graduate course, BLD 835 Hemostasis and Thrombosis. Her attached manuscript provides basic information about apixaban’s indications and efficacy and makes an intriguing reference to apixaban as a potential means for dementia management. Click here for Michele’s manuscript, “Can Apixaban Help Reduce the […]

read more

Comments (0)

Anticoagulant Therapy

Nov 30 2022

george

November, 2022 Quick Question: PT/INR

The stem or our November 2022 Quick question asked, If you use the PT when no warfarin is being measured, how do you report the results? Our 51 participants responded as follows: Report both PT and INR: 34 [66%] Report PT/MRI ratio: 0 Report PT only: 14 [27%] Report INR only: 4 [7%] Answer 2 […]

read more

Comments (3)

Anticoagulant Therapy

Nov 17 2022

george

Ultracentrifuge Plasma?

Received 11-13-22: Hello, We have an ultracentrifuge in our lab that is used in our chemistry department for lipemic samples. In the coagulation department,

read more

Comments (0)

Anticoagulant Therapy

Nov 15 2022

george

The Dilute Thrombin Time Measures DTIs

Here is the abstract of a pre-publication release comparing direct thrombin inhibitor results from the plasma-diluted thrombin time [DTT] to the partial thromboplastin time [PTT]:

read more

Comments (0)

Anticoagulant Therapy

Nov 9 2022

george

November, 2022 Quick Question

Please visit and respond to our November 2022 Quick Question, submitted by Dave McGlasson. The question asks, "If you use the PT when no warfarin is being measured, how do you

read more

Comments (0)

Blog